سعر نيباسكو 5مجم 30 قرص 2024

Nebasco 5 mg tablets, pack of 30 (FPI > Tabuk, Egypt): nebivolol hydrochloride, a selective beta-1 blocker antihypertensive.

• Treatment of hypertension, to lower blood pressure; may be used alone or in combination with other antihypertensive agents.Population: AdultsDailyMed / FDA

• Common: headache, fatigue, dizziness, diarrhoea, nausea, insomnia, chest pain, bradycardia, dyspnoea, rash, peripheral oedema.International label, same formulation · DailyMed / FDA

• Severe bradycardia; heart block greater than first degree; cardiogenic shock; decompensated heart failure; sick sinus syndrome (unless permanent pacemaker); severe hepatic impairment; hypersensitivity to nebivolol or excipients.International label, same formulation · DailyMed / FDA

• Abrupt discontinuation can exacerbate angina and cause myocardial infarction or ventricular arrhythmias — taper when possible.International label, same formulation · DailyMed / FDA
• May mask signs of hypoglycaemia and hyperthyroidism; caution in diabetes and bronchospastic disease.International label, same formulation · DailyMed / FDA

• CYP2D6 inhibitors (e.g. quinidine, fluoxetine, paroxetine)MajorMay increase nebivolol exposure.DailyMed / FDA
• Verapamil / diltiazem / other negative inotropesMajorAdditive effects on AV conduction and cardiac function.DailyMed / FDA
• ClonidineMajorBeta-blocker withdrawal before clonidine withdrawal to reduce rebound hypertension risk.DailyMed / FDA

• US PLLR: human data insufficient; third-trimester beta-blocker exposure may cause neonatal hypotension, bradycardia, hypoglycaemia and respiratory depression; rat embryofetal/perinatal lethality at about the MRHD.International label, same formulation · DailyMed / FDA
• Not recommended during nursing (US label); present in rat milk.International label, same formulation · DailyMed / FDA

• Nebivolol hydrochloride: Beta-adrenergic receptor blocker; antihypertensive mechanism not definitively established (reduced heart rate and contractility, reduced sympathetic outflow, renin suppression, vasodilation) per the US BYSTOLIC label.